ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1987

Recessive Coding and Regulatory Mutations in FBLIM1 Underlie the Pathogenesis of Sterile Osteomyelitis

Allison Cox1, Benjamin W Darbro2, Ronald Laxer3, Xinyu Bing4, Alexis Finer5, Albert Erives6, Vinit Mahajan7, Alexander G Bassuk1 and Polly Ferguson8, 1Pediatrics and Interdisciplinary Graduate Program in Genetics, University of Iowa Carver College of Medicine, Iowa City, IA, 2Department of Pediatrics and Interdisciplinary Graduate Program in Genetics, University of Iowa Carver College of Medicine, Iowa City, IA, 3Div of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Department of Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA, 5Pediatrics, University of Iowa Carver College of Medicine, Iowa City, IA, 6Biology and Interdisciplinary Graduate Program in Genetics, University of Iowa Carver College of Medicine, Iowa City, IA, 7Department of Ophthalmology and Visual Sciences,, University of Iowa Carver College of Medicine, Iowa City, IA, 8Department of Pediatrics--Rheumatology, University of Iowa Carver College of Medicine, Iowa City, IA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Autoinflammatory Disease, bone disease, Chronic recurrent multifocal osteomyelitis (CRMO), genetic disorders and pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics

Session Type: ACR Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:  Chronic recurrent multifocal osteomyelitis (CRMO) is a rare, pediatric, autoinflammatory disease characterized by bone pain due to sterile osteomyelitis, and is often accompanied by psoriasis or inflammatory bowel disease. There is evidence for a genetic basis in several syndromic forms of the disease including the Deficiency of the Interleukin-1 Receptor Antagonist (DIRA; due to mutations in IL1RN), Majeed syndrome (due to mutations in LPIN2) and murine chronic multifocal osteomyelitis (due to mutations in Pstpip2). However, for the majority of cases of CRMO, the genetic basis remains unknown.

Methods:  We used whole exome and Sanger sequencing, gene expression microarray and Luciferease assays to identify additional CRMO susceptibility genes.

Results:  Via whole-exome sequencing, we detected a homozygous mutation in the filamin-binding domain of FBLIM1 in an affected child with consanguineous parents. Microarray analysis of bone marrow macrophages from the CRMO murine model (cmo mouse) determined that the Fblim1 ortholog is the most differentially expressed gene, further implicating it in disease pathogenesis. In addition, studies suggest FBLIM1/FBLP1 is an anti-inflammatory molecule regulated by STAT3, and one involved in bone remodeling via ERK1/2 phosphorylation and the subsequent regulation of RANKL activation. We sequenced FBLIM1 in 96 CRMO subjects and found a second proband with compound heterozygous mutations in FBLIM1 composed of a novel frameshift mutation in exon 6 and a rare regulatory variant. The enhancer contains binding sites for STAT3 and NR4A2. Enhancer activity of a 1-kb region around the mutation was validated by luciferase assays in fluoride-treated SaOS2 cells, as was the effect of the mutation on regulatory activity. In SaOS2 cells, overexpressing the regulatory mutation showed the flanking region acts as an enhancer, and the mutation ablates enhancer activity. 

Conclusion:  Our data implicate FBLIM1 in the pathogenesis of CRMO and autoinflammatory disease.


Disclosure: A. Cox, None; B. W. Darbro, None; R. Laxer, None; X. Bing, None; A. Finer, None; A. Erives, None; V. Mahajan, None; A. G. Bassuk, None; P. Ferguson, None.

To cite this abstract in AMA style:

Cox A, Darbro BW, Laxer R, Bing X, Finer A, Erives A, Mahajan V, Bassuk AG, Ferguson P. Recessive Coding and Regulatory Mutations in FBLIM1 Underlie the Pathogenesis of Sterile Osteomyelitis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/recessive-coding-and-regulatory-mutations-in-fblim1-underlie-the-pathogenesis-of-sterile-osteomyelitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/recessive-coding-and-regulatory-mutations-in-fblim1-underlie-the-pathogenesis-of-sterile-osteomyelitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology